HomeAnswersHematologyhemophilia a

How does Emicizumab impact factor replacement?

This Premium Q&A, reviewed and published, features a real conversation between an iCliniq user and a physician.

Patient's Query

Hello doctor,

A patient with severe hemophilia A and suspected intracranial bleeding after a minor car accident. Factor levels are less than 1 %. The patient is on Emicizumab prophylaxis, with the last dose administered five days ago. A CT head scan is pending. The ER is inquiring about the immediate need for factor replacement, while hematology is calculating the rescue dose. How urgent is the factor replacement before imaging?

Kindly help.

Thank you.

Answered by Dr. Ayesha Khanum

Education:

MBBS

Professional Bio:

Dr. Ayesha Khanum is a dedicated Pediatric Hematology specialist known for her compassionate, patient-centered approach to complex blood disorders in children. She focuses on accurate diagnosis, individualized treatment, and long-term care to support healthy growth and development. With deep clinical expertise and a calm, reassuring manner, Dr. Khanum is committed to improving outcomes and quality of life for young patients and their families.

This doctor is not available for online consultations on the platform anymore.

Hello,

Welcome to icliniq.com.

I can understand your concern.

Factors should be replaced as soon as available to prevent further bleeding and cranial damage. It is better to start with FFP (fresh frozen plasma) followed by infused factors. After that, CT (computed tomography) imaging can be done, as the priority is to prevent bleeding and manage the emergency. Imaging can be performed later since the factor level is very low. A minimum of 30 percent factor level is required, and ideally, 50 percent if possible. I hope this clarifies the situation. Take care, and God bless you. Please send me the imaging report and factor levels once completed. I hope this information helps you.

Please let us know if you have any further queries.

Thank you.

Medically reviewed by iCliniq medical review team
Published At April 10, 2025
Reviewed At April 11, 2025

Education:

MBBS

Professional Bio:

Dr. Ayesha Khanum is a dedicated Pediatric Hematology specialist known for her compassionate, patient-centered approach to complex blood disorders in children. She focuses on accurate diagnosis, individualized treatment, and long-term care to support healthy growth and development. With deep clinical expertise and a calm, reassuring manner, Dr. Khanum is committed to improving outcomes and quality of life for young patients and their families.

This doctor is not available for online consultations on the platform anymore.

Same symptoms don't mean you have the same problem. Consult a doctor now!

Education:

MBBS

Professional Bio:

Dr. Ayesha Khanum is a dedicated Pediatric Hematology specialist known for her compassionate, patient-centered approach to complex blood disorders in children. She focuses on accurate diagnosis, individualized treatment, and long-term care to support healthy growth and development. With deep clinical expertise and a calm, reassuring manner, Dr. Khanum is committed to improving outcomes and quality of life for young patients and their families.

This doctor is not available for online consultations on the platform anymore.

Listen to related tracks in our music library
Comprehensive Second Opinion

Ask your health query to a doctor online

*guaranteed answer within 4 hours

Disclaimer: No content published on this website is intended to be a substitute for professional medical diagnosis, advice or treatment by a trained physician. Seek advice from your physician or other qualified healthcare providers with questions you may have regarding your symptoms and medical condition for a complete medical diagnosis. Do not delay or disregard seeking professional medical advice because of something you have read on this website. Read our Editorial Process to know how we create content for health articles and queries.